Trevi Therapeutics (TRVI) Cash from Investing Activities (QoQ) (2018 - 2026)
Trevi Therapeutics (TRVI) Cash from Investing Activities (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Trevi Therapeutics |
2.08 Bn |
1.91 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
155.43% |
| Dec 31, 2025 |
39.91% |
| Sep 30, 2025 |
-1,851.65% |
| Jun 30, 2025 |
73.77% |
| Mar 31, 2025 |
58.32% |
| Dec 31, 2024 |
-411.36% |
| Sep 30, 2024 |
176.99% |
| Jun 30, 2024 |
134.21% |
| Mar 31, 2024 |
-162.99% |
| Dec 31, 2023 |
-28.57% |
| Sep 30, 2023 |
-8.44% |
| Jun 30, 2023 |
119.14% |
| Mar 31, 2023 |
118.55% |
| Dec 31, 2022 |
-896.00% |
| Dec 31, 2020 |
66.67% |
| Mar 31, 2019 |
90.22% |
| Dec 31, 2018 |
-9,300.00% |
| Sep 30, 2018 |
110.00% |
| Jun 30, 2018 |
82.46% |
